Vivent Health
Vivent Health
Denver, Colorado, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-10-01 | NCT07473778 | |
| A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 | HIV-1-infection | Recruiting | Phase 2 | 2026-09-04 | NCT07645287 | |
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 | HIV-1-Infection | Active, not recruiting | Phase 3 | 2026-05-29 | NCT06630299 | |
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 | HIV-1-infection | Active, not recruiting | Phase 3 | 2026-04-30 | NCT06630286 | |
| Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV | HIV-1 Infection | Active, not recruiting | Phase 2 | 2026-02-04 | NCT05052996 |